PYC Therapeutics Ltd Asset Resilience Ratio

Latest as of June 2025: 83.51%

PYC Therapeutics Ltd asset resilience ratio. PYC Therapeutics Ltd (PYC) has an Asset Resilience Ratio of 83.51% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PYC Therapeutics Ltd (PYC) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

AU$153.05 Million

≈ $108.29 Million USD Cash + Short-term Investments

Total Assets

AU$183.28 Million

≈ $129.68 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of PYC Therapeutics Ltd (2017–2025)

Asset resilience ratio of PYC Therapeutics Ltd from 2017 to 2025. This chart shows how PYC Therapeutics Ltd's Asset Resilience Ratio has changed over time. See PYC free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down PYC Therapeutics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of PYC Therapeutics Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$153.05 Million	83.51%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$153.05 Million	83.51%

Asset Resilience Insights

Very High Liquidity: PYC Therapeutics Ltd maintains exceptional liquid asset reserves at 83.51% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

PYC Therapeutics Ltd Industry Peers by Asset Resilience Ratio

Compare PYC Therapeutics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

PYC Therapeutics Ltd Asset Resilience Ratio by Year (2017–2025)

PYC Therapeutics Ltd asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for PYC Therapeutics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	83.51%	AU$153.05 Million ≈ $108.29 Million	AU$183.28 Million ≈ $129.68 Million	+10.21pp
2024-06-30	73.30%	AU$66.87 Million ≈ $47.32 Million	AU$91.24 Million ≈ $64.56 Million	+31.40pp
2023-06-30	41.90%	AU$15.57 Million ≈ $11.02 Million	AU$37.17 Million ≈ $26.30 Million	-22.29pp
2022-06-30	64.19%	AU$29.11 Million ≈ $20.60 Million	AU$45.35 Million ≈ $32.09 Million	-24.70pp
2021-06-30	88.89%	AU$51.50 Million ≈ $36.44 Million	AU$57.94 Million ≈ $41.00 Million	+8.28pp
2020-06-30	80.61%	AU$25.43 Million ≈ $17.99 Million	AU$31.55 Million ≈ $22.32 Million	-11.45pp
2018-06-30	92.05%	AU$3.15 Million ≈ $2.23 Million	AU$3.42 Million ≈ $2.42 Million	-4.00pp
2017-06-30	96.05%	AU$9.94 Million ≈ $7.03 Million	AU$10.35 Million ≈ $7.32 Million	--

pp = percentage points

About PYC Therapeutics Ltd

AU:PYC Australia Biotechnology

Market Cap

$794.49 Million

AU$1.12 Billion AUD

Market Cap Rank

#9547 Global

#236 in Australia

Share Price

AU$1.88

Change (1 day)

-2.84%

52-Week Range

AU$1.07 - AU$2.91

All Time High

AU$2.91